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Introduction
Esophageal cancer (EC) is the 8th most common cancer and the 6th most frequent cause of cancer mortality worldwide, 
causing over 400,000 deaths in 2008.1 80% of esophageal 
cancers occur in developing countries. Esophageal cancer rates 
vary greatly between and within countries. There are two large 
bands of high risk, across central Asia from the Caspian Sea to 
northern China (the Central Asian Esophageal Cancer Belt) and 
from eastern to southern Africa.2 Within these bands, EC inci-
dence rates are 50 – 100/100,000 population/year, whereas in 
most other areas of the world they are < 10/100,000/year.  
At the eastern end of the Central Asian Esophageal Cancer 
Belt is Iran. The highest rates of EC in Iran occur in Golestan 
Province, in the northeast of the country. In the 1970s, scientists 
from Iran and the International Agency for Research on Cancer 
(IARC) recorded EC incidence rates of 165/100,000/year in men 
and 195/100,000/year in women,3 the highest rates of EC ever 
recorded in the world, and they began initial studies to determine 
its cause, but sociopolitical events in Iran in 1979 stopped these 
studies. Since the 1970s, EC rates in Golestan have declined,4,5 but 
despite this decline, EC remains the most frequent malignancy in 
northeastern Iran,4–6 and the results of the Golestan population-
based Cancer Registry show that the truncated ASR of EC is still 
very high, especially in the eastern parts of Golestan Province 
(Gonbad and Kalaleh).4,5
Adenocarcinoma and squamous cell carcinoma are the main 
histologic subtypes of EC. In the 1960s, about 90% of EC cases 
throughout the world were esophageal squamous cell carcinoma 
(ESCC).2 Recent studies, however, have shown a declining trend 
in the rate of ESCC and a sharply increasing trend in the rate of 
esophageal adenocarcinoma in the United States and some Eu-
ropean countries.7–9 But the situation seems to be different in the 
developing world, where all of the highest risk populations are. 
Reports from developing countries have not shown the changing 
pattern of EC histologies that has been seen in western countries. 
For example, ESCC comprises more than 90% of EC cases in 
northeastern Iran.6,10 So, ESCC is the most important type of EC 
in the developing world and a major health problem in high risk 
areas including northeastern Iran. 
ESCC develops by progression from dysplastic lesions within 
the squamous epithelium of the esophagus 2. In studies in a high-
risk population in China, esophageal squamous dysplasia (ESD) 
was shown to be the only clinically important precursor lesion for 
(6&&DQGGLIIHUHQWKLVWRORJLFJUDGHVRI(6'LGHQWL¿HGGLIIHUHQW
levels of ESCC risk.11,12 
Various factors have been shown to increase the risk of ESCC,13 
including tobacco smoking,14,15 heavy alcohol drinking,14 opium 
consumption,15 nass chewing,15 hot tea consumption,16 mate 
drinking,17 low intake of fruits and vegetables,18QXWULHQWGH¿FLHQ-
cies,19–21 tooth loss,22 and low socioeconomic status.23 Alcohol and 
tobacco are the most important risk factors for ESCC in low-risk 
populations,24 but its etiology in high risk areas is less clear. Ex-
posure to polycyclic aromatic hydrocarbons (PAHs) has been sug-
gested as an important risk factor for developing ESCC in many 
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populations.13 The aim of this paper is to discuss different aspects 
of the relationship between PAH exposure and ESCC. 
Characteristics of PAHs   
PAHs are a group of compounds that are formed by incomplete 
combustion of organic matter, including vegetation, fossil fuels 
and oil products.25,26 They are composed of two or more con-
densed aromatic rings27¿JXUHDQGWKH\DUHGLVWULEXWHGDFURVV
gaseous and particulate phases.28 In the environment, they are 
found in soil, water, air and food.29 Exposure to PAHs may oc-
cur through inhalation, ingestion or percutaneous penetration.28,29 
They distribute to various organs, especially the liver.29 PAHs 
themselves are chemically inert and hydrophobic, but they are 
metabolized within cells to their active forms, the diol-epoxides. 
This change results in PAHs binding to cellular macromolecules 
such as DNA,27,30 causing the formation of PAH-DNA adducts, 
which lead to mutations in proto-oncogenes and tumour-suppres-
sor genes.28 Generating other reactive intermediates by a one-
electron oxidation process is another carcinogenic mechanism of 
PAHs. This process may cause chemical alkylation of DNA and 
result in potentially mutagenic depurination.31
Determination of exposure to PAHs
Two ways to assess the level of exposure to PAHs are measure-
ment of the external dose and measurement of the internal dose. 
7KHH[WHUQDOGRVHFDQEHTXDQWL¿HGE\PRQLWRULQJWKHFRQFHQWUD-
WLRQRI3$+VLQWKHDLUDQGIRRG7KHLQWHUQDOGRVHUHÀHFWLQJWKH
total uptake of PAHs, may be assessed by monitoring of PAHs or 
WKHLUPHWDEROLWHVLQERG\ÀXLGVRUWLVVXHV32 Therefore, biological 
monitoring, making an accurate estimation of the individual inter-
nal dose, has been considered as useful indicator for human expo-
sure to PAHs.33 Urinary 1-hydroxypyrene concentration is a valid 
marker for assessing the level of recent exposure to PAHs.32,34–36 
It has also been reported to be a sensitive biomarker for low dose 
PAH exposure.36,37 Zhao et al. reported that the maximum con-
centration of 1-hydroxypyrene in urine samples was found in the 
evening (21:00 – 23:00), and recommended this as a suitable time 
for sample collection for evaluation of PAHs.38 Urinary concen-
tration of 1-hydroxypyrene glucoronide (1-OHPG) has also been 
VKRZQWREHVLJQL¿FDQWO\KLJKHU LQ LQGLYLGXDOVH[SRVHGWRKLJK
levels of PAH.39,40 In a study of 10 healthy non-smoking men, 24 
hours after starting a high-PAH diet (charbroiled beef), the level 
of urinary 1-OHPG increased 10 – 80 fold above baseline levels. 
Urinary concentration of this marker decreased to near baseline 
levels by 1 – 3 days after ending the diet.40 
Seidel et al. have suggested hydroxylated metabolites of naph-
WKDOHQHÀXRUHQHSKHQDQWKUHQHÀXRUDQWKHQHDQGS\UHQHDVYDOLG
biomarkers for monitoring PAH exposure.41–45 They were also re-
ported to be valid biomarkers of occupational exposure to PAHs,46 
especially lowly condensed volatile PAHs.43 It has been suggested 
that measuring hydroxyphenanthrene in addition to 1-hydroxypy-
rene may provide more complete information about PAH expo-
sure in individuals.43 
Urinary levels of unmetabolised naphthalene and phenanthrene 
have also been shown to be promising surrogates for assessing 
PAH exposure.45 Naphthalene was suggested as a good biomarker 
for assessing occupational exposure to PAHs.28
PAH-DNA adducts are more persistent indicators of PAH expo-
sure than are urinary markers.36 The levels of PAH-DNA adducts 
in easily accessible WBCs have been suggested as valid biomark-
ers in exposure assessment as well as intervention studies.47 The 
level of this marker in peripheral WBCs has been reported to re-
ÀHFWERWKRFFXSDWLRQDODQGGLHWDU\H[SRVXUHWR3$+V48–50 There 
was a positive association between the level of PAH-DNA ad-
Figure 1.6WUXFWXUHVRIFDUFLQRJHQLFDQGQRQFDUFLQRJHQLFXQVXEVWLWXWHGSRO\F\FOLFDURPDWLFK\GUR
FDUERQV$GRSWHGIURP+DUYH\
3$+VDQG(VRSKDJHDO&DQFHU
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ducts in WBCs and recent exposure to PAHs from consumption 
of charbroiled food51 or smoking.52 But, as Gyorffy et al. showed, 
the levels of PAH-DNA adducts in WBCs may not appropriately 
UHÀHFWLWVOHYHOVLQWDUJHWWLVVXHV53 So, tissue levels of PAH-DNA 
adducts are considered a more valid indicator of exposure to PAH 
in recent studies. van Gijssel et al. detected PAH-DNA adducts 
LQROGSDUDI¿QHPEHGGHGHQGRVFRSLFELRSVLHVRI WKHHVRSKDJXV
from Linxian, China.54 They observed nuclear PAH-DNA adduct 
VWDLQLQJLQIRXURXWRI¿YHVDPSOHVDQGFRQFOXGHGWKDWROGELRSV\
samples are appropriate for assessing past exposure to PAHs.54 
There are some limitations in using PAH-DNA adducts in epide-
miologic studies, including non-linearity at high exposures, lack 
of sensitivity to low exposures, the large amounts of DNA needed 
for PAH-DNA adduct measurements, the problem of inter- and 
intra-lab variability in results using the 32P-postlabeling measure-
ment technique, and the use of surrogate tissues (e.g. WBCs) in-
stead of the target tissues.13 Nevertheless, these markers have been 
successfully used in establishing links between PAH exposure and 
risk of several cancers.           
7RULEDHWDOLGHQWL¿HG3$+VLQKXPDQKDLUVDPSOHVE\+3/&
ZLWKÀXRUHVFHQFHGHWHFWLRQ7KH\UHSRUWHGWKDW3$+DQDO\VLVLQ
hair samples is a good biomarker for assessing PAH exposure.55 
%HVNLGHWDOXVHGÀXRUHVFHQFHLQVLWXK\EULGL]DWLRQ),6+ZLWK
whole chromosome painting to assess the levels of exposure to 
carcinogenic PAHs.56 
In a recent study from Iran, immunohistochemical staining of tar-
get tissue with an anti-PAH antibody (8E11) was successfully used 
for assessing PAH exposure.57 It would be interesting to know if 
such measurements are correlated with the prevalence of genetic 
mutations or levels of PAH-DNA adducts in the same tissue or in 
a more accessible tissue such as buccal epithelium.58 Answers to 
these questions would be helpful for conducting future epidemio-
logical studies and surveillance programs in high risk areas.
PAHs and cancers
Some PAH compounds, including benzo-a-anthracene , benzo-
EÀXRUDQWKHQHEHQ]RMÀXRUDQWKHQHEHQ]RNÀXRUDQWKHQHEHQ-
zo-a-pyrene, dibenz-a,h-anthracene, and indeno-1,2,3-c,d-pyrene, 
are considered to be human carcinogens.36,59 PAHs have been 
shown to induce carcinogenic changes in a number of human tis-
VXHV7KHUHSRUWRI3HUFLYDOO3RWWLQZDVWKH¿UVWHYLGHQFHRI
an association between PAH (soot) exposure and cancer (scrotal 
cancer) in chimney sweeps.60 PAH exposure has now been docu-
mented to increase the risk of cancers of the lung,61,62 bladder,61 
breast,63 pancreas64,65 and prostate.65 PAH mutagenesis was also 
found in human epidermal keratinocytes in culture.66 Benzo-a-py-
rene, the most common PAH to cause cancer in human, has been 
FODVVL¿HG DV DJURXS FDUFLQRJHQE\ ,$5&59 Recently, IARC 
also reported that diesel engine exhaust (an important source of 
exposure to PAHs) has a carcinogenic effect in humans and clas-
VL¿HGLWDVDJURXSFDUFLQRJHQ67 So PAHs have been shown to 
have carcinogenic effects in a number of human organs.
PAH-induced P53 mutations 
P53 is a tumor suppressor gene which is frequently mutated in 
human cancers. P53 mutations occur in about 40% of lung can-
cers.68 Smoking tobacco, which contains many carcinogens, in-
cluding PAHs, has been shown to cause lung cancer. So, PAH-
induced P53 mutation was suggested as a possible mechanism in 
the pathogenesis of lung cancer. PAH-induced P53 mutations are 
mostly G:C to T:A transversions,69 and they are poorly repaired. 
Puisieux et al. showed the direct role of PAHs in the induction of 
PXWDWLRQVLQWKH3JHQHLQOXQJFDQFHUIRUWKH¿UVWWLPH69 Re-
cently, Gao et al. suggested that PAHs may have the potential to 
induce P53 mutations in the cervix of mice.70 It has been proposed 
that the most common locations of P53 mutations, known as mu-
tational hotspots, are preferred targets for PAHs.69 Other studies 
similarly reported that PAH-DNA adducts preferentially occur 
at p53 mutational hotspots.71 Shen et al. reported P53 mutation 
due to formation of PAH o-quinones, one of the ultimate carcino-
gens of PAHs, in cigarette smokers.72 It was suggested that PAH 
o-quinones cause P53 inactivation by generating endogenous re-
active oxygen species.73 P53 mutation was reported to be attrib-
uted to direct PAH-induced DNA damage rather than selection of 
Figure 2.8ULQDU\FRQFHQWUDWLRQVRIK\GUR[\S\UHQHJOXFXURQLGH 2+3* LQQRQVPRNLQJ LQGLYLGXDOV IURP*ROHVWDQ ,UDQ  Rio 
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7XULQ,WDO\3RKDQJ6RXWK.RUHD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DQG.RUHDQFKLOGUHQ
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pre-existing endogenous mutations.68 Because of the clear causal 
relationship between tobacco smoking and lung cancer, most 
previous investigations about PAH-induced P53 mutations have 
been conducted on lung cancer. But other malignancies, including 
ESCC, are also known to have a strong relationship with tobacco 
smoke carcinogens, especially PAHs. Brennan et al. reported a 
fourfold increase in the prevalence of P53 mutations in heavy 
smoking EC patients as compared to nonsmokers.74 The results 
of a recent study in northeastern Iran also suggested PAH-induced 
P53 mutations in ESCC cases. In this study, G:C to A:T transver-
sions were the most common type of mutation, followed by G:C 
to T:A transversions.75 Further investigations are needed to clarify 
if PAH-induced P53 mutations play a major role in the pathogen-
esis of ESCC, as they do in the case of lung cancer.  
Role of PAHs in the pathogenesis of ESCC
More than half of cancers occur in surface epithelia (such as the 
esophageal epithelium) that are in direct contact with the exter-
nal environment.76 Direct exposure to PAHs has been suggested 
WRFRQWULEXWHVLJQL¿FDQWO\WRFDUFLQRJHQHVLVLQWKHVHWLVVXHV66 A 
dose-response relationship was found between PAH exposure 
and development of EC in mice.77 Gustavsson et al. reported a 
VLJQL¿FDQWH[FHVVRIHVRSKDJHDOFDQFHULQFKLPQH\VZHHSVDQG
thought that the most probable explanation was a direct action 
of PAHs on the esophageal mucosa.61 The results of studies from 
Canada,65 Germany,78 Sweden79 and Brazil80 have also shown an 
excess risk of esophageal cancer in PAH-exposed individuals. 
Barbecuing and grilling, important sources of exposure to PAHs, 
have also been associated with an elevated risk of esophageal can-
cer.81 Roth et al. found high levels of PAHs in food samples ob-
tained from a high risk area for ESCC in China,82 and high levels 
of urine 1-OHPG in the local inhabitants,83 suggesting a possible 
role for PAH exposure in ESCC pathogenesis there. Exposure to 
widespread and very high levels of PAHs was also reported from 
a high risk area for ESCC in the northeast of Iran84 (Figure 2). 
0DUMDQLHWDO UHSRUWHGVLJQL¿FDQWO\KLJKHU OHYHOVRI3$+'1$
adducts in ESCC tumor tissue than in normal esophageal tissues 
from these same cases or from control individuals, and concluded 
that PAHs are risk factors for ESCC in this same population in 
Golestan Province, Iran.85 And in another recent study from this 
area, immunohistochemical staining with an anti-PAH antibody 
(8E11) was performed on non-tumoral esophageal epithelial tis-
sues obtained from ESCC patients and normal controls.57 There 
was a striking dose-response relationship between the intensity 
of 8E11 and ESCC case status, suggesting a causal role for PAH 
exposure in the pathogenesis of ESCC57 (Table 1). The effects of 
inherited genetic variation on the levels of such PAH adducts may 
also be important in this context,86 and need to be further investi-
gated in future studies.      
Sources of exposure to PAHs
1. Dietary sources
)RRGVKDGEHHQLGHQWL¿HGDVLPSRUWDQWVRXUFHVRIKXPDQH[SR-
sure to PAHs.87 Diet is usually the main source of PAH exposure 
in non-smoking individuals who are not exposed to occupational 
PAHs.25,26 Contamination of foods by PAHs may occur during 
food processing, such as smoking or cooking, or as a result of ac-
cidental environmental contamination, such as atmospheric pollu-
tion of vegetables.88,89
Agricultural crops may be an important source of exposure to 
PAHs.90 By accumulating on the surface of plants exposed to pol-
luted air, PAHs may be present in most crops.91 Because of the 
hydrophobic nature of PAHs, it is believed that the contamination 
of agricultural crops by these compounds comes mainly from the 
air rather than from the soil.92 
The Total Human Environmental Exposure Study from the 
US showed that foods account for more than 96% of the daily 
intake of carcinogenic PAHs.93 Vyskocil et al. reported no rela-
tionship between PAH levels in air and urinary concentration of 
1-hydroxypyrene, suggesting that other factors (e.g. dietary intake 
of PAHs) may be potentially more important sources of internal 
dose.94 An analysis of UK food samples reported that cereals and 
oils/fats were the most important source of PAHs in the UK diet, 
followed by fruits, sugar and vegetables.89 De Vos et al. assessed 
Dutch total diet samples and reported that sugar and sweets, ce-
reals, oils, fats and nuts were the major sources of PAHs.95 The 
results of a study from Italy also showed that food was the main 
source of PAH exposure, suggesting cereals, milk products, meat, 
vegetables and fruits as the major contributors to total PAH in-
take.96 Falco et al. assessed the dietary intake of PAHs in Cata-
lonia, Spain. They found the highest levels of PAHs in cereals, 
meat and meat products.97 Chemical analysis of foodstuffs in 
northeastern Iran in 1970s did not show high levels of PAHs in 
the major dietary items.98 But in another study from this region, 
Hakami et al. suggested that diet is a major source of exposure to 
PAH99 (Table 2). 
The level of PAH in food may be affected by methods of food 
processing and preparation. Some studies reported no change in 
WKH3$+FRQWHQW RIÀRXUGXULQJ WKHEUHDGEDNLQJSURFHVV)RU
example, Dennis et al. reported similar amounts of PAHs in wheat 
ÀRXUDQGEUHDGPDGHIURPWKLVÀRXU100 And high levels of PAHs 
were reported in both raw and cooked food samples from a high 
risk area of ESCC in China.82 But many other studies showed 
that some methods of food processing have documented effects 
on PAH levels in food. High levels of PAHs have been reported 
in smoked foods.101 The concentration of PAHs in smoked meat 
products was shown to be more dangerous when an uncontrolled 
smoking process (without appropriate technology) is used.29 
Charbroiled foods have been shown to contain some of the high-
est PAH levels among frequently used foods, suggesting them as 
a major source of dietary exposure to PAHs in populations which 
commonly charbroil their food.51 The results of a study on Ital-
ian foods showed the highest levels of PAHs in pizza prepared 
in a wood-burning oven and in barbecued meat.96 Eating meat 
prepared by grilling, roasting or broiling was also reported as an 
important source of exposure to PAHs.102 The type of heat source 
(direct versus indirect), the geometry of the grill, grilling dura-
tion, the use of marinating sauces, and the fat content of the food 
were some contributors to PAH formation in grilled and smoked 
foods.103 In a recent study from northeastern Iran (unpublished 
GDWDWKHUHZDVDVLJQL¿FDQWUHODWLRQVKLSEHWZHHQFRRNLQJPHWK-
od and the level of PAH-DNA adducts in peripheral lymphocytes. 
7KHUHVXOWVVKRZHGWKDW3$+H[SRVXUHLVVLJQL¿FDQWO\KLJKHULQ
individuals using deep frying methods for cooking foods. Meat 
tikka, whole grilled chicken, meat burgers and grilled vegetables 
were major dietary sources of exposure to PAHs in Kuwait.103
Drinking mate, a water infusion of the herb yerba mate (Ilex 
paraguayensis), is a common habit in southern South Ameri-
3$+VDQG(VRSKDJHDO&DQFHU
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ca.104 In previous studies, both the temperature and the quantity 
of mate consumption have been associated with increased risk 
of ESCC.17,105 Mate drinking has also been associated with in-
creased risk of other smoking-related cancers, including cancers 
of the lung,106 larynx,107 oral cavity and oropharynx,108 kidney109 
and bladder,110,111DIWHUDGMXVWPHQWIRUVPRNLQJ$VLJQL¿FDQWSRVL-
tive relationship was reported between drinking mate and urinary 
level of 1-OHPG in southern Brazil, suggesting that this factor is 
an important source of PAH exposure in this area.80 Laboratory 
measurement of PAHs in commercial yerba mate leaves and in 
both cold and hot water infusions of these leaves showed very 
high levels of benzo-a-pyrene and other carcinogenic PAHs, and 
suggested that drinking a gourd of mate in the traditional manner 
can expose an individual to as much benzo-a-pyrene as smoking 
a typical pack of 20 cigarettes.112 So the PAH content of food and 
the method of food processing and preparation are major contrib-
utors to human exposure to PAHs from dietary sources.
2. Tobacco smoking and opium consumption 
7REDFFRVPRNLQJKDVEHHQLGHQWL¿HGDVDPDMRUVRXUFHRIH[-
posure to PAHs.113–115$VLJQL¿FDQWSRVLWLYHUHODWLRQVKLSKDVEHHQ
reported between urinary level of 1-OHPG and smoking.39,80,116 
Van Rooij et al. reported that active smoking and PAH contain-
ing food products account for 99% of urinary excretion of PAH 
biomarkers in individuals who are not occupationally exposed to 
PAHs.117 In a study from the US, individuals with recent smok-
ing had 1-OHPG concentrations 10-fold that of non-smokers.102 
Second hand smoke exposure was also correlated with high 
1-OHPG concentration.102/HHHWDOUHSRUWHGVLJQL¿FDQWO\KLJKHU
urinary 1-OHPG levels in South Korean children whose parents 
smoke at home.118 The results of studies conducted in the 1970s 
in northeastern Iran showed high levels of opium consumption in 
this region and indicated that PAHs are a major active component 
responsible for its mutagenicity.98,119 In a recent study, smoking, 
nass consumption and opium consumption were all found to be 
VLJQL¿FDQWVRXUFHVRI3$+H[SRVXUHLQ*ROHVWDQ3URYLQFH,UDQ84 
and high exposure to PAH may be one explanation for the report-
ed association between opium or tobacco use and higher risk of 
ESCC in northeastern Iran.15 The proportion of the excess risk of 
ESCC due to PAH exposure from smoking and opium consump-
WLRQKDVQRW\HWEHHQFOHDUO\LGHQWL¿HG7KLVLVDQLQWHUHVWLQJLVVXH
for future studies in this area and other similar populations such as 
those in central China.  
 
3. Occupational exposure
 Occupation is also an important source of exposure to PAHs. 
The level of exposure to PAHs varies between different occu-
pations.120 High levels of PAH exposure have been reported in 
foundry workers,37 chimney sweeps,61 blast furnace and coke-
oven workers,39 vendors of broiled food,121 and steel plant and 
waste incineration workers.39,122,123 Coke-oven exposure is a major 
predictor of urinary 1-OHP levels.115 The results of a study from 
the UK showed that coke-oven workers had the highest levels 
of exposure to benzo[a]pyrene.124 The highest levels of urinary 
1-OHPG were reported in timber impregnators using creosote 
and workers using coal tar. Both dermal and inhalation exposure 
were suggested as possible explanations for high PAH exposure 
in the above mentioned occupations.124 In a study from the US, the 
highest levels of exposure to PAHs were detected in coke-oven 
workers, asphalt workers and diesel-exposed workers.45 Job is an 
important indicator of exposure to PAH, and should be considered 
in future related studies. 
4. Indoor air pollution
 Combustion of solid fuels for cooking and heating is the major 
source of indoor air levels of PAHs.125 China is the largest pro-
ducer and consumer of coal throughout the world. A substantial 
portion of domestic energy needs in China are supplied by coal, a 
Quintile Controls (n) Cases (n) Adjusted OR (95% CI)2
1 20 2 Reference
2 21 6 2.49 (0.41 – 15.3)
3 21 14 5.59 (1.03 – 30.2)
4 21 19 10.9 (2.07 – 57.4)
5 20 50 26.8 (5.28 – 136)
1From Abedi-Ardekani B et al. Gut. 2010;59:1178–1183; 2Adjusted for age, sex, education, ethnicity, tobacco use and opium use
Table 1. $GMXVWHG25VDQG&,VIRUWKHDVVRFLDWLRQEHWZHHQVWDLQLQJLQWHQVLW\RIPRQRFORQDODQWLERG\(DQGHVRSKDJHDOVTXDPRXVFHOO
FDUFLQRPDLQWKH*ROHVWDQ&DVH&RQWURO6WXG\
Food item Daily Benzo(a)pyrene intake (ng/day)
Cases (n=40) Golestan controls (n=40) Fars controls (n=40)
Bread+rice+water BaP 99.0±39.3* 91.4±31.6 70.6±27.1c
Bread BaP 60.9±31.8a 48.1±20.4 28.4±14.9d
Rice BaP 24.7±16.8a 33.5±21.2 34.6±18.9
Water BaP (water+tea) 13.4±6.7b 9.7±4.3 7.5±2.9e
1From Hakami R et al., Nutrition and Cancer 2008;60:216–221;*mean±SD;aP<0.05, b P<0.001 between cases and Golestan controls; cP<0.01,d P<0.001,e 
P<0.05   between the two control groups.
Table 2.%HQ]R>D@S\UHQH%D3LQWDNHIURPEUHDGULFHDQGZDWHULQ*ROHVWDQDQG)DUVSURYLQFHV,UDQ
Population Main sources Other sources
West Tobacco smoke Car exhaust, Coal smoke
China Coal smoke Tobacco smoke, Car exhaust
Iran Unknown Tobacco smoke, Car exhaust
Brazil Tobacco smoke, Mate Barbequed meat, Car exhaust
Table 3.7KHPDLQDQGRWKHUVRXUFHVRI3$+H[SRVXUHLQWKH:HVWDQGLQGLIIHUHQWSRSXODWLRQVZLWKDKLJKULVNRI(6&&
*5RVKDQGHO66HPQDQL50DOHN]DGHKHWDO
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known source of PAH.125 Thus, domestic coal, especially “smoky 
coal”, combustion is known as a main source of high PAH expo-
sure in China.126 Mumford et al. showed very high PAH levels in 
indoor air samples from Chinese homes, especially ones which 
used smoky coal in unvented stoves for heating and cooking.127 
6LPLODU ¿QGLQJV ZHUH UHSRUWHG LQ RWKHU VWXGLHV IURP &KLQD125 
High PAH concentrations were also reported in soot deposits from 
coal-burning stoves in Chinese homes.128 Gevao et al. also report-
ed high levels of indoor PAHs in indoor air and dust in Kuwait.129 
Housewives and children usually spend a lot of time at home. 
This may lead to high levels of exposure to PAHs from indoor 
PAH sources in these groups. Therefore, housewives, children 
DQGDOOLQGLYLGXDOVVSHQGLQJDORWRIWLPHLQKRPHVZLWKVLJQL¿-
cant indoor air pollution may be considered as high risk groups in 
studies related to the effects of PAH exposure on human health.  
   
5. Environmental air pollution
 There are many sources of PAHs in environmental air. Un-
NQRZQVRXUFHVRIHQYLURQPHQWDO3$+VPDNHLWGLI¿FXOWWRDVVHVV
the exact level of PAH exposure from the environment. Various 
methods may be used to estimate the concentration of PAHs in the 
environment. For example, the level of PAHs in the environment 
LVUHÀHFWHGE\WKHLUSUHVHQFHLQVRPHXQFRRNHGIRRGVRUIUXLWV25 
PAH levels in olive fruits have been considered one measure of 
air pollution.91
It has been suggested that constituents of car exhaust, industrial 
emissions and smoke are the main sources of outdoor air PAHs. In 
a study from the US, outdoor concentrations of PAHs were higher 
in highly urbanized areas (containing many cars and industries) 
than in the Great Lakes region.93 The results of another study from 
an area near a large city bus terminal showed higher air levels 
of PAHs on weekdays and during morning rush hours, probably 
UHODWHG WRURDGWUDI¿F1307KH\DOVRUHSRUWHGVLJQL¿FDQWO\KLJKHU
PAH levels in areas closer to the bus terminal.130 Marr et al. report-
ed high levels of PAHs along Mexico City’s roadways, suggesting 
YHKLFOHWUDI¿FDVDVRXUFHRIKXPDQH[SRVXUHWR3$+V1316LJQL¿-
cantly higher 1-OHPG concentrations have also been reported in 
individuals who recently traveled in automobiles for more than 
3 hours.102 The results of a study from Shenzhen, China, showed 
VLJQL¿FDQWO\KLJKHUOHYHOVRI3$+VLQDUHDVZLWKPDQ\URDGVWKDQ
in forested land.132 Individuals living in the vicinity of an alumi-
num plant in Canada were exposed to high levels of PAHs.133 
Sediments from certain commercial and residential ponds have 
also been suggested as potential sources of exposure to PAHs.134
Identifying the nature and characteristics of environmental 
sources of exposure to PAHs as well as the levels of PAH expo-
sure from these sources are interesting issues for future studies. 
These investigations are especially important in high risk areas of 
PAH-related cancers such as northeastern Iran.
Effects of genetic changes on an individual’s re-
sponse to PAH exposure 
 
Genetic factors may affect an individual’s response to PAH 
exposure.86 Usually, p450 enzymes (CYP1A1, CYP1A2, CYP 
1B1) metabolize PAHs (such as benzo-a-pyrene) to biologically 
active intermediates (such as benzo-a-pyrene diol expoxide) and 
GHWR[L¿FDWLRQ HQ]\PHV LQFOXGLQJ JOXWDWKLRQH 6WUDQVIHUDVHV
(GSTM1, GSTP1, GSTT1), UDP-glucuronosyltransferases, and 
sulphotransferases, conjugate these PAH metabolites and de-
toxify them.26 But genetic polymorphisms may affect the activity 
of these enzymes and make individuals more or less susceptible 
to the carcinogenic effects the same PAH exposure.86 Roth et al. 
showed an association between the inactive polymorphism of 
the GSTM1 gene and the presence of esophageal squamous dys-
plasia, the precursor of ESCC, in a PAH-exposed population in 
China.135$OVRDVLJQL¿FDQWO\KLJKHUH[SUHVVLRQRIWKHDU\OK\GUR-
carbon receptor (AhR) gene, which codes for the cell membrane 
receptor for PAHs, was reported in subjects from the same popu-
lation who had a positive family history of upper gastrointestinal 
cancers, suggesting that these individuals might be more suscep-
tible to PAH-related carcinogenesis.136 And Abnet et al. reported 
a strong association between CYP1B1 and urinary 1-OHPG con-
centrations in a Brazilian population with a high risk of ESCC.137 
So, in addition to sources of exposure, genetic susceptibility to 
3$+UHODWHG FDUFLQRJHQHVLVPD\DOVR LQÀXHQFH WKH UHODWLRQVKLS
between PAH exposure and ESCC pathogenesis.
Identifying the main sources of PAH exposure
PAH exposure has now been documented to be an important risk 
factor for developing ESCC. Thus, reducing the levels of exposure 
to PAHs may be an effective strategy for controlling ESCC, espe-
cially in high risk areas. Appropriate PAH-reduction interventions 
may differ, depending on the main sources of PAH exposure in 
each area. For example, Li et al. showed that replacement of open 
SLWVWRYHVE\FORVHGVWRYHVHTXLSSHGZLWKDFKLPQH\VLJQL¿FDQWO\
reduced PAH exposure in Peru.138 Identifying the main sources of 
exposure to PAHs will result in maximum effectiveness of such 
PAH-reduction interventions. The major sources of PAH exposure 
KDYHEHHQ LGHQWL¿HG LQVRPHSRSXODWLRQVZLWKKLJK(6&&UDWHV
(Table 3). But the situations in other high risk populations such as 
the northeast of Iran remain unclear. Previous studies conducted in 
the 1970s in northeastern Iran showed low levels of PAHs in food 
samples,139,140 and the investigations by the joint Iran-IARC study 
group on major dietary items in northern Iran showed no unusual 
levels of carcinogens such as PAHs in food samples.141 These stud-
ies suggested that food is not the main source of PAH exposure 
in this area. On the other hand, Hakami et al. reported that food 
may be an important source of exposure to PAHs in Golestan Prov-
ince.99 As reported by Kamangar et al. smoking and opium con-
sumption are probably not the main sources of exposure to PAHs 
in this area.84 Further evaluations, including environmental studies, 
are needed to identify the major sources of PAH exposure in this 
region as well as other high risk populations. 
Conclusion
An association has been found between PAH exposure and de-
velopment of ESCC in many populations. Identifying the main 
VRXUFHVRIH[SRVXUHWR3$+VLVWKH¿UVWDQGPRVWLPSRUWDQWVWHS
for conducting appropriate PAH-reduction interventions to con-
trol ESCC, especially in high risk areas. Coal smoke and drink-
LQJPDWHKDYHEHHQVXJJHVWHGDVLPSRUWDQWPRGL¿DEOHVRXUFHVRI
PAH exposure in China and Brazil, respectively. But the primary 
source of exposure to PAHs in other high risk areas for ESCC, 
VXFKDVQRUWKHDVWHUQ,UDQKDVQRW\HWEHHQLGHQWL¿HG7KXVHQYL-
ronmental studies to determining important sources of PAH ex-
posure should be considered as a high priority in future research 
projects in these areas.
3$+VDQG(VRSKDJHDO&DQFHU
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